Ara
Toplam kayıt 13, listelenen: 1-10
How telemedicine can improve the quality of care for patients with alzheimer’s disease and related dementias? A narrative review
(MDPI, 2022)
Background and Objectives: Dementia affects more than 55 million patients worldwide, with a significant societal, economic, and psychological impact. However, many patients with Alzheimer’s disease (AD) and other related ...
SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of kawasaki disease?
(Rockefeller University Press, 2021)
Multisystem inflammatory syndrome in children (MIS-C) emerged in April 2020 in communities with high COVID-19 rates. This new condition is heterogenous but resembles Kawasaki disease (KD), a well-known but poorly understood ...
The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists
(AVES, 2020)
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel acute infectious disease that has rapidly reached staggering pandemic proportions. This review addresses ...
Headache onset after vaccination against SARS-CoV-2: A systematic literature review and meta-analysis
(BMC, 2022)
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are used to reduce the risk of developing Coronavirus Disease 2019 (COVID-19). Despite the significant benefits in terms of reduced ...
From asymptomatic to critical illness: Decoding various clinical stages of COVID-19
(The Scientific and Technological Research Council of Turkey, 2021)
The clinical course of COVID-19 is variable, with clinical manifestation ranging from 81% mild course to 14% severe course along with 5% critical course in patients. The asymptomatic course is reported to potentially range ...
Covid-19: Pathogenesis, genetic polymorphism, clinical features and laboratory findings
(TUBITAK Scientific & Technological Research Council of Turkey, 2020)
COVID-19 caused by a novel agent SARS-CoV-2 progressed to a pandemic condition and resulted in a major public health concern worldwide, leading to social and economic issues at the same time. The pathogenesis of COVID-19 ...
E-leadership and teleworking in times of COVID-19 and beyond: What we know and where do we go
(Frontiers Media S.A., 2020)
Suddenly, COVID-19 has changed the world and the way people work. Companies had to accelerate something they knew was imminent in the future, but not immediate and extremely humongous. This situation poses a huge challenge ...
Systematic review and meta-analysis of tocilizumab therapy versus standard of care in over 15,000 COVID-19 pneumonia patients during the first eight months of the pandemic
(MDPI, 2021)
Background. Tocilizumab is an anti-IL-6 therapy widely adopted in the management of the so-called "cytokine storm" related to SARS-CoV-2 virus infection, but its effectiveness, use in relation to concomitant corticosteroid ...
Vaccines and autoimmunity—From side effects to ASIA syndrome
(MDPI, 2023)
Since vaccines are in fact manufactured chemical compounds such as drugs, the appearance of side effects following their use is not surprising. Similarly, as the main goal of vaccines is to stimulate the immune system ...
Innate and adaptive immunity during SARS-CoV-2 infection: Biomolecular cellular markers and mechanisms
(MDPI, 2023)
The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, other human coronaviruses (hCoVs) exist. Historical ...